Inpharmatis Team participated in Kazakhstan Pharmaceutical Forum 2025, held in Almaty on 11-12 February, 2025. 

The Forum brought together regulatory authorities, pharmaceutical companies, distributors, and industry experts to discuss key topics such as market trends, regulatory frameworks, digitalization and local production development. 

“Inpharmatis is committed to supporting pharmaceutical companies from around the world, including Europe and CIS as they enter or expand in Kazakhstan market. We provide advanced solutions and extended expertise in regulatory strategy and compliance within EAEU, GMP inspection preparation and execution, and digitalisation of Regulatory Affairs (RA), Pharmacovigilance (PV) and Quality divisions via our eSolutions Department. Kazakhstan is one of the most perspective markets in Central Asia, and we are excited to share our knowledge insights in support of our Customers towards successful navigation within this regulatory landscape,” said Sergey Gareishin, Head of Sales at Inpharmatis. 

As part of its ongoing expansion in Central Asia, Inpharmatis provides expert services in Regulatory Affairs of medicinal products, medical devices and food supplements, Pharmacovigilance, and GMP/GDP inspections. 

For more information about our services and collaboration opportunities, please contact us at: info@inpharmatis.com.